arXiv:2604. 19191v2 Announce Type: replace-cross Abstract: Deploying AI-based anomaly detection across diverse clinical imaging settings remains challenging because most existing methods rely on modality-specific architectures, anatomical priors, or extensive retraining, limiting their use as general-purpose screening tools.
By Pritam Kar, Gouri Lakshmi S, Saptarshi Bej
arXiv:2605. 24609v2 Announce Type: replace-cross Abstract: Artificial intelligence is increasingly integrated into radiotherapy workflows, yet such pipelines remain vulnerable to out-of-distribution image data that may introduce unexpected behavior in clinical tasks.
By Mustafa Kadhim, Viktor Rogowski, Emilia Persson, Camila Gonzalez, Andr\'e Haraldsson, Sofie Ceberg, Mikael Nilsson, Malin K\"ugele, Sven B\"ack, Christian Jamtheim Gustafsson
arXiv:2507. 21164v2 Announce Type: replace-cross Abstract: Unsupervised anomaly detection (UAD) aims to detect anomalies without labeled data, a necessity in many machine learning applications where anomalous samples are rare or not available.
By Nicolas Pinon (MYRIAD), Robin Trombetta (MYRIAD), Carole Lartizien (MYRIAD)
Unified visual anomaly detection seeks to train a single detector that can be deployed across categories, domains, and application scenarios. In the few-shot transfer regime, the key challenge is to estimate an episode-specific boundary for an unseen target category from a small support set.
arXiv:2602. 02124v2 Announce Type: replace-cross Abstract: Drug-induced toxicity is a leading cause of preclinical and early-clinical failure, making early detection critical.
By Olga Graf, Dhrupal Patel, Peter Gro{\ss}, Charlotte Lempp, Matthias Hein, Fabian Heinemann
arXiv:2512. 17605v2 Announce Type: replace-cross Abstract: Robust mammography registration is essential for clinically relevant applications like tracking disease progression in breast tissue.
By Svetlana Krasnova, Emiliya Starikova, Ilia Naletov, Andrey Krylov, Dmitry Sorokin
arXiv:2608. 10271v1 Announce Type: cross Abstract: Breast density classification is a critical component of breast cancer risk assessment, yet AI models often struggle to generalize across clinical sites due to vendor-specific acquisition styles.
By Hongyi Pan, Gorkem Durak, Halil Ertugrul Aktas, Andrea Mia Bejar, Mustafa Ege Seker, Nebile Alibeyoglu, Rumeysa Guclu, Rana Gunoz Comert Bozkurt, Sibel Ozkan Gurdal, Neslihan Cabioglu, Beyza Ozcinar, Ravza Yilmaz, Vahit Ozmen, Erkin Aribal, Sukru Mehmet Erturk, Yalda Zafari, Mohamed Mabrok, Kayhan Batmanghelich, Mohammad Yaqub, Ziyue Xu, Ulas Bagci
Breast DCE-MRI AI is increasingly being explored for breast-level classification of no-lesion, benign, and malignant findings, beyond conventional lesion-centered diagnosis. Within this broader diagnostic scope, however, patient-specific background variability remains a major source of imaging confounding across classification tasks.
arXiv:2606. 20108v1 Announce Type: cross Abstract: Image quality control is vital for a wide range of downstream applications.
By Pengwei Wang, Jos\'e Morano, Qian Wan, Hrvoje Bogunovi\'c
arXiv:2606. 07381v1 Announce Type: cross Abstract: Background and Purpose: Automated detection of focal cortical dysplasia (FCD) requires large volumes of voxelwise lesion-delineated MRI data, which are difficult to acquire.
By Prabhjot Kaur, Hakim Ouaalam, Sedat Kandemirli, Sanjay P. Prabhu, Simon K. Warfield
arXiv:2607. 08219v2 Announce Type: replace-cross Abstract: The privacy requirements of medical data and its substantial variations across organs and modalities hinder the clinical implementation of medical AI.
By Junbin Mao, Xu Tian, Jianchun Zhu, Ludi Li, Jin Liu
arXiv:2607. 08219v1 Announce Type: cross Abstract: The privacy requirements of medical data and its substantial variations across organs and modalities hinder the clinical implementation of medical AI.
By Junbin Mao, Xu Tian, Jianchun Zhu, Ludi Li, Jin Liu